[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2025 World Erlotinib Hydrochloride Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 168 pages | ID: 20D8725B675EN
HeyReport

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Erlotinib Hydrochloride , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Erlotinib Hydrochloride market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc)
  • South America (Brazil, Argentina etc)
  • Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
  • 25mg
  • 100mg
  • 150mg
By End-User / Application
  • Non-small Cell Lung Cancer
  • Pancreatic Cancer
By Company
  • Roche
  • Cipla
  • Mylan
  • Teva
  • OSI Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Beacon Pharmaceuticals
  • Raichem Lifesciences
  • United Biotech
  • CJ Corporation
  • Vivimed Labs
  • Boryung Pharmaceutical
  • Taj Pharmaceuticals
  • Pharmascience
  • Natco Pharma
  • Intas Pharmaceuticals
  • RPG Life Sciences
  • Pharmascience
  • Schwarz Pharma
  • Dr. Reddy’s Laboratories
  • Glenmark Pharmaceuticals
  • Chugai Pharmaceutical
  • DKSH
  • Firma Chun Cheong
  • Kremers Urban Pharmaceuticals
  • Ortat
  • Zuellig Pharma
1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.ICON HEALTH & FITNESS, INC. ROCHE

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Cipla
12.3 Mylan
12.4 Teva
12.5 OSI Pharmaceuticals
12.6 Glenmark Pharmaceuticals
12.7 Beacon Pharmaceuticals
12.8 Raichem Lifesciences
12.9 United Biotech
12.10 CJ Corporation
12.11 Vivimed Labs
12.12 Boryung Pharmaceutical
12.13 Taj Pharmaceuticals
12.14 Pharmascience
12.15 Natco Pharma
12.16 Intas Pharmaceuticals
12.17 RPG Life Sciences
12.18 Pharmascience
12.19 Schwarz Pharma
12.20 Dr. Reddy’s Laboratories
12.21 Glenmark Pharmaceuticals
12.22 Chugai Pharmaceutical
12.23 DKSH
12.24 Firma Chun Cheong
12.25 Kremers Urban Pharmaceuticals
12.26 Ortat
12.27 Zuellig Pharma

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

LIST OF TABLES

Table Global Erlotinib Hydrochloride Market and Growth by Type
Table Global Erlotinib Hydrochloride Market and Growth by End-Use / Application
Table Global Erlotinib Hydrochloride Revenue (Million USD) by Vendors (2017-2019)
Table Global Erlotinib Hydrochloride Revenue Share by Vendors (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume (Volume) by Vendors (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table Global Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume (Volume) by Type (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume Share by Type (2017-2019)
Table Global Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table Global Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume Share by End-Use / Application (2017-2019)
Table Global Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table Global Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume (Volume) by Regions (2017-2019)
Table Global Erlotinib Hydrochloride Market Volume Share by Regions (2017-2019)
Table North America Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table North America Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table North America Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table North America Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table North America Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table North America Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table Europe Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table Europe Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table Europe Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table Europe Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table Europe Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table South America Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table South America Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table South America Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table South America Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table South America Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market Share by Type (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Erlotinib Hydrochloride Market Share by Regions (2017-2019)
Table Global Erlotinib Hydrochloride Market (Million USD) Forecast by Regions (2020-2025)
Table Global Erlotinib Hydrochloride Market Share Forecast by Regions (2020-2025)
Table Global Erlotinib Hydrochloride Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Erlotinib Hydrochloride Market Volume Share Forecast by Regions (2020-2025)
Table Global Erlotinib Hydrochloride Market (Million USD) Forecast by Type (2020-2025)
Table Global Erlotinib HydrochlorideMarket Share by Forecast Type (2020-2025)
Table Global Erlotinib Hydrochloride Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Erlotinib Hydrochloride Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Sales Revenue, Volume, Price, Cost and Margin of Cipla
Table Sales Revenue, Volume, Price, Cost and Margin of Mylan
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of OSI Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Beacon Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Raichem Lifesciences
Table Sales Revenue, Volume, Price, Cost and Margin of United Biotech
Table Sales Revenue, Volume, Price, Cost and Margin of CJ Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of Vivimed Labs
Table Sales Revenue, Volume, Price, Cost and Margin of Boryung Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Taj Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Pharmascience
Table Sales Revenue, Volume, Price, Cost and Margin of Natco Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of RPG Life Sciences
Table Sales Revenue, Volume, Price, Cost and Margin of Pharmascience
Table Sales Revenue, Volume, Price, Cost and Margin of Schwarz Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Dr. Reddy’s Laboratories
Table Sales Revenue, Volume, Price, Cost and Margin of Glenmark Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Chugai Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of DKSH
Table Sales Revenue, Volume, Price, Cost and Margin of Firma Chun Cheong
Table Sales Revenue, Volume, Price, Cost and Margin of Kremers Urban Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Ortat
Table Sales Revenue, Volume, Price, Cost and Margin of Zuellig Pharma

LIST OF FIGURES

Figure Global Erlotinib Hydrochloride Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Erlotinib Hydrochloride Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Erlotinib Hydrochloride Market Volume (Volume) and Growth Forecast (2020-2025)


More Publications